Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The rise of deadly insect sting allergies: Is there a cure?

01.08.2013
Report suggests venom immunotherapy can make sufferers 'less allergic'

If you think summer insects are done setting their sights on ruining your outdoor gathering, think again. August's hot and dry climate is the perfect breeding ground for insects, especially yellow jackets. And for the millions of Americans allergic to insect stings, these late summer bugs can be deadly.

According to a report released today in the August issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), insect sting allergy is increasing, affecting five percent of the population. But what much of the population may not understand is that there is something that can be done about it.

"While it does not always cure insect sting allergy, venom immunotherapy, a form of allergy shots, can almost always prevent severe reactions to stings," said David Golden, MD, article author and ACAAI fellow. "It usually provides long-lasting immunity even after the treatment is stopped."

Even 10 to 20 years after having an allergic reaction from an insect sting, the chance of having another reaction continues to be up to 70 percent in adults and 30 percent in children. Venom immunotherapy doesn't completely eliminate the risk of an allergic reaction to insect stings, noted Dr. Golden, but almost all of the reactions that do occur (five to 10 percent) are mild, with less than two percent chance of a severe reaction while on treatment. Protection takes effect as soon as the full dose is reached, usually within 2 to 3 months of treatment.

"Allergy sufferers who have had an allergic reaction to an insect sting should be under the care of a board-certified allergist," said Dr. Golden. "For those with severe reactions, prescribed emergency epinephrine should always be carried. Sufferers should also talk with their allergist to see if venom immunotherapy is right for them. It's not always a cure, but it is close."

As with other forms of allergy shots, the recommended duration of venom immunotherapy is three to five years. Because relapse can occur, it's best for patients to be regularly tested by an allergist. Venom immunotherapy actually prevents severe reactions, and improves quality of life because people no longer have to fear getting stung.

To reduce the chance of getting stung by late summer insects, the ACAAI advises:

Cover up with pants and long-sleeved shirts when gardening or working outdoors
Avoid walking barefoot in the grass
Take caution when eating or drinking anything sweet
Don't wear sweet smelling perfumes, hairsprays and deodorants when heading outdoors

Avoid brightly colored clothing with floral patterns

For more information about insect sting allergy and to locate an allergist in your area, visit http://www.AllergyAndAsthmaRelief.org.

About ACAAI

The ACAAI is a professional medical organization of more than 5,700 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit http://www.AllergyandAsthmaRelief.org. Join us on Facebook, Pinterest and Twitter.

Nancy Ryan | EurekAlert!
Further information:
http://www.acaai.org

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Gold shines through properties of nano biosensors

17.08.2017 | Physics and Astronomy

Greenland ice flow likely to speed up: New data assert glaciers move over sediment, which gets more slippery as it gets wetter

17.08.2017 | Earth Sciences

Mars 2020 mission to use smart methods to seek signs of past life

17.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>